Xtx Topco LTD Ptc Therapeutics, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$24.69 - $40.12 $764,673 - $1.24 Million	30,971 New	30,971 $947,000
Q3 2023 Nov 13, 2023	BUY	$22.41 - $41.99 $369,518 - $692,373	16,489 New	16,489 $369,000
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $179,609 - $217,123	-4,853 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$37.95 - $49.37 $73,623 - $95,777	-1,940 Reduced 28.56%	4,853 $205,000
Q1 2021 May 14, 2021	BUY	$46.8 - $68.92 $317,912 - $468,173	6,793 New	6,793 $322,000

219

78.2M

111K

30.6K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.